Advances in Neurophysiology and the Treatment of Parkinson’s Disease
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Neurobiology and Clinical Neuroscience".
Deadline for manuscript submissions: 30 November 2025 | Viewed by 163
Special Issue Editor
Interests: movement disorders; hypokinetic movement disorders; Parkinson’s disease; atypical parkinsonisms; progressive supranuclear palsy; corticobasal syndome; multiple system atrophy; levodopa; neurophysiology; clinical neurophysiology; neurophysiology of movement disorders; peripheral diseases; myasthenia gravis
Special Issue Information
Dear Colleagues,
Numerous studies of levodopa treatment, neurophysiology, and neuroplasticity in Parkinson’s disease (PD) have been conducted in recent years. However, the mechanisms underlying the pathophysiology of and neuroplasticity in PD remain largely unknown. This Special Issue aims to highlight recent advances in the evaluation of the synergistic effect between levodopa and motor learning on neurophysiological markers and neuroplasticity, especially in early PD. Topics of interest include the pharmacologic role of levodopa, the importance of neurophysiological markers as diagnostic tools for the disease, the application of motor learning strategies, and the multifactorial influence on neuroplasticity. We invite contributions that provide insights into novel observations on neurophysiological and treatment features with the aim of deeply understanding how to optimize diagnostic and therapeutic strategies for PD, especially at the early stage of the disease.
Dr. Giorgia Sciacca
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- movement disorders
- hypokinetic movement disorders
- Parkinson’s disease
- levodopa
- treatment
- neurophysiology
- neuroplasticity
- motor learning
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
